Value of serum AFP, AFP-L3. PIVKA -II in predicting the recurrence of hepatocellular carcinoma after radiofrequency ablation (RFA)
Original article | No. 53 (2019)
Journal of Clinical Medicine Hue Central Hospital, No. 53 (2019)
Original article

Value of serum AFP, AFP-L3. PIVKA -II in predicting the recurrence of hepatocellular carcinoma after radiofrequency ablation (RFA)

DOI: 10.38103.53.11
10.38103.53.11
  • Phan Huynh Vi
  • Le Ngoc Hung
  • Nguyen Hoang Be
  • Tran Minh Sang
  • Nguyen Dinh Song Huy
Phan Huynh Vi
Le Ngoc Hung
Nguyen Hoang Be
Tran Minh Sang
Nguyen Dinh Song Huy

Downloads

Download data is not yet available.
PDF (Tiếng Việt)     52    73

Abstract

A

https://doi.org/10.38103.53.11

References

A

Published 27-01-2025
Fulltext
PDF (Tiếng Việt)     52    73
Language
Tiếng Việt
Issue No. 53 (2019)
Section Original article
DOI 10.38103.53.11
Keywords
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Copyright (c) 2019 Journal of Clinical Medicine Hue Central Hospital

Vi, P. H., Hung, L. N., Be, N. H., Sang, T. M., & Huy, N. D. S. (2025). Value of serum AFP, AFP-L3. PIVKA -II in predicting the recurrence of hepatocellular carcinoma after radiofrequency ablation (RFA). Journal of Clinical Medicine Hue Central Hospital, 11(53), 71–79. https://doi.org/10.38103.53.11
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX
© 2024 Hue Central Hospital - Designed by OJSVN